Загрузка...
Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
BACKGROUND: A key goal for HIV-1 envelope immunogen design is the induction of cross-reactive neutralizing antibodies (nAbs). As AIDS vaccine recipients will not be exposed to strains exactly matching any immunogens due to multiple HIV-1 quasispecies circulating in the human population worldwide, he...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3905655/ https://ncbi.nlm.nih.gov/pubmed/24444350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4690-11-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|